You are not logged in
You need to be a member to print this page.
Sign up for free membership, or log in.
Find out more about our membership benefits
Clinical Articles
Br J Cardiol 2011;18:233-237 10.5837/bjc.2011.005
Alcohol septal ablation in hypertrophic obstructive cardiomyopathy
Alcohol septal ablation (ASA) is an alternative therapeutic method to the gold-standard surgical myectomy in the treatment of symptomatic left ventricular outflow tract (LVOT) obstruction
Br J Cardiol 2011;18:238-240 10.5837/bjc.2011.006
Aspirin taking in a south Wales county
In order to determine the taking of regular aspirin within a representative community sample of adults residing in the south Wales county of Caerphilly, we
Br J Cardiol 2011;18:246-248 10.5837/bjc.2011.009
Recurrent stent thrombosis with dual antiplatelet resistance: the role of platelet function testing
Platelet activation is an important part of the pathophysiology of acute coronary syndromes. Inhibition of this by antiplatelet agents forms an important part of the
Br J Cardiol 2011;18:241-242 10.5837/bjc.2011.007
Mitral valve leaflet and free-floating left atrial thrombi with ‘rhupus’ and antiphospholipid syndrome
A 27-year-old Arab woman with history of seronegative rheumatoid arthritis for four years presented with a three-day history of multiple joint pains and swelling, along with
Br J Cardiol 2011;18:243-245 10.5837/bjc.2011.008
Cabergoline as an adjunct for early left ventricular recovery in peripartum cardiomyopathy
Outcome in patients with peripartum cardiomyopathy (PPCM) is variable. Recovery of left ventricular function is observed in between 23% and 51% of cases at six
Br J Cardiol 2011;18:167–69
Drugs for diabetes: part 6 GLP-1 receptor agonists
The glucagon-like peptide-1 (GLP-1) receptor agonists are a new class of injected drugs for the treatment of type 2 diabetes. They mimic the action of
Br J Cardiol 2011;18:171–76
MyAction: an innovative approach to the prevention of cardiovascular disease in the community
We developed and piloted an innovative family-centred preventive cardiology programme (MyAction) that aimed to both integrate the care of patients with vascular disease with that
Br J Cardiol 2011;18:178
Lifestyle advice and drug therapy post-myocardial infarction: a survey of UK current practice
Reducing morbidity and mortality among post-myocardial infarction (MI) patients requires the implementation of effective secondary measures. This survey examined current practice by assessing the view
Br J Cardiol 2011;18:179
Ranolazine in the management of chronic stable angina
Ranolazine has been evaluated in three trials in patients with stable angina (MARISA, CARISA and ERICA) and one large trial of patients with non-ST elevation
Br J Cardiol 2011;18:180–84
Community-based cardiovascular risk reduction: age and the Framingham risk score
This study examined the effect of a community-based intervention on the natural rise with age of the Framingham 10-year risk score. Patients in the 45–64-year-old